Humanized antibodies to LIV-1 and use of same to treat cancer
US-9228026-B2 · Jan 5, 2016 · US
This page is not indexed by search engines while we improve data quality.
Sussman Django — Human Necessities
Sussman Django holds 1 patent in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Sussman Django |
| Technology | Human Necessities |
| Patents in slice | 1 |
| Recent patents in slice | 0 |
| First year | 2016 |
| Last year | 2016 |
Representative patents
Notable publications linking Sussman Django to Human Necessities.
Humanized antibodies to LIV-1 and use of same to treat cancer
US-9228026-B2 · Jan 5, 2016 · US
Humanized antibodies to LIV-1 and use of same to treat cancer
US-9228026-B2 · Jan 5, 2016 · US
Humanized antibodies to LIV-1 and use of same to treat cancer
US-9228026-B2 · Jan 5, 2016 · US
Humanized antibodies to LIV-1 and use of same to treat cancer
US-9228026-B2 · Jan 5, 2016 · US
Recent filings
Latest patents from Sussman Django in Human Necessities.
Humanized antibodies to LIV-1 and use of same to treat cancer
US-9228026-B2 · Jan 5, 2016 · US
Humanized antibodies to LIV-1 and use of same to treat cancer
US-9228026-B2 · Jan 5, 2016 · US
Humanized antibodies to LIV-1 and use of same to treat cancer
US-9228026-B2 · Jan 5, 2016 · US
Humanized antibodies to LIV-1 and use of same to treat cancer
US-9228026-B2 · Jan 5, 2016 · US
Humanized antibodies to LIV-1 and use of same to treat cancer
US-9228026-B2 · Jan 5, 2016 · US
Related pages
Navigate to parent entity pages.